Addition of Onivyde to Standard Care Improves Survival, Does Not Worsen Quality of Life in Pancreatic Cancer
The addition of Onivyde to some chemotherapy regimens for pancreatic cancer improved survival and did not affect patients' quality of life.
New Class of Agents Moves to Frontline in Lung Cancer
The first-line treatment paradigm for lung cancer is shifting.
New Study Shows Shorter Survival for Thin Patients With Colorectal Cancer
Though having a high body mass index (BMI) is associated with a higher risk for colorectal cancer, patients who are thinner may not do as well after treatment for metastatic colorectal cancer (mCRC).